Dicyclomine has an initial half-life of about 1.8 hours, meaning most of the drug clears from your bloodstream within roughly 9 to 12 hours after your last dose. However, a secondary elimination phase extends this timeline, and full clearance likely takes closer to 24 hours for a single dose. Several personal factors can push that window longer.
How Quickly Dicyclomine Is Absorbed and Eliminated
After you swallow a tablet, dicyclomine is rapidly absorbed and reaches its peak concentration in your blood within 60 to 90 minutes. From there, plasma levels drop with an initial half-life of approximately 1.8 hours. A half-life is the time it takes for the amount of drug in your blood to fall by half. After five half-lives, a drug is generally considered cleared from your system.
Five cycles of 1.8 hours puts the math at about 9 hours, but that only accounts for the first phase of elimination. When researchers tracked blood levels beyond 9 hours (out to 24 hours after a single dose), they found a secondary elimination phase with a noticeably longer half-life. The exact duration of this second phase hasn’t been precisely quantified in published studies, but it means trace amounts of the drug linger in the body longer than the initial math suggests. A reasonable estimate for near-complete clearance after a single oral dose is somewhere in the range of 18 to 24 hours.
Where the Drug Goes After It Leaves Your Blood
About 79.5% of a dicyclomine dose is excreted through urine, making the kidneys the primary exit route. A smaller fraction, around 8.4%, leaves through the feces. The remaining percentage is unaccounted for in published data, and the exact metabolic pathways in the liver have not been formally studied. Because the kidneys handle the bulk of elimination, anything that affects kidney function can slow the process down.
Why It May Stay Longer in Some People
If you have reduced kidney function, dicyclomine can build up in your body because the main elimination route is less efficient. This is especially relevant for older adults, who are more likely to have age-related declines in kidney performance. The FDA label specifically flags this population as being at greater risk for toxic reactions and recommends cautious dosing.
Liver health matters too, even though dicyclomine’s metabolic pathway hasn’t been fully mapped. Any drug that passes through the liver before being excreted can be affected by impaired liver function. People with liver or kidney disease should expect the drug to remain active in their system for a longer period than the standard estimates.
Body composition, hydration, and age also play a role. Older adults tend to have lower water volume and slower organ function, both of which can extend how long any medication lingers.
Oral Tablets vs. Intramuscular Injection
Most people take dicyclomine as an oral tablet or capsule, but it also comes in an injectable form given into the muscle. The intramuscular version is about twice as bioavailable as the oral form, meaning your body absorbs a much higher proportion of the dose. This doesn’t necessarily change the half-life, but it does mean more of the drug enters your bloodstream in the first place. A higher starting concentration takes longer to fall below detectable levels, so the injectable form effectively stays in your system a bit longer than an equivalent oral dose.
How This Relates to Dosing Frequency
Dicyclomine is typically taken four times a day, spaced roughly every four to six hours. This schedule exists precisely because the drug’s effects wear off relatively quickly. Each new dose adds to whatever remains from the previous one, creating a steady-state level in your blood. If you’ve been taking it regularly and then stop, it will take longer to fully clear than if you only took a single dose. For someone on a steady regimen, expect the drug to be effectively out of your system within one to two days after the final dose, depending on your kidney function and overall health.
The therapeutic relief from a single dose, the actual reduction in gut cramping, generally aligns with the dosing schedule. Most people notice the effects fading well before their next scheduled dose, which tracks with that short initial half-life.